Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 190

1.

2,3,5,4'-tetrahydroxystilbene-2-O-β-D-glucoside (THSG) attenuates human platelet aggregation, secretion and spreading in vitro.

Xiang K, Liu G, Zhou YJ, Hao HZ, Yin Z, He AD, Da XW, Xiang JZ, Wang JL, Ming ZY.

Thromb Res. 2014 Feb;133(2):211-7. doi: 10.1016/j.thromres.2013.11.006. Epub 2013 Nov 15.

PMID:
24332167
2.

Neferine exerts its antithrombotic effect by inhibiting platelet aggregation and promoting dissociation of platelet aggregates.

Zhou YJ, Xiang JZ, Yuan H, Liu H, Tang Q, Hao HZ, Yin Z, Wang J, Ming ZY.

Thromb Res. 2013 Aug;132(2):202-10. doi: 10.1016/j.thromres.2013.05.018. Epub 2013 Jun 14.

PMID:
23773522
3.

Protective effects of 2,3,5,4'-tetrahydroxystilbene-2-O-beta-d-glucoside, an active component of Polygonum multiflorum Thunb, on experimental colitis in mice.

Wang X, Zhao L, Han T, Chen S, Wang J.

Eur J Pharmacol. 2008 Jan 14;578(2-3):339-48. Epub 2007 Oct 25.

PMID:
17963744
4.

Parnaparin, a low-molecular-weight heparin, prevents P-selectin-dependent formation of platelet-leukocyte aggregates in human whole blood.

Maugeri N, Di Fabio G, Barbanti M, de Gaetano G, Donati MB, Cerletti C.

Thromb Haemost. 2007 Jun;97(6):965-73.

PMID:
17549299
6.

Antiplatelet activity of loureirin A by attenuating Akt phosphorylation: In vitro studies.

Hao HZ, He AD, Wang DC, Yin Z, Zhou YJ, Liu G, Liang ML, Da XW, Yao GQ, Xie W, Xiang JZ, Ming ZY.

Eur J Pharmacol. 2015 Jan 5;746:63-9. doi: 10.1016/j.ejphar.2014.10.059. Epub 2014 Nov 13.

PMID:
25445049
7.

2, 3, 5, 4'-tetrahydroxystilbene-2-O-beta-D-glucoside (THSG) induces melanogenesis in B16 cells by MAP kinase activation and tyrosinase upregulation.

Jiang Z, Xu J, Long M, Tu Z, Yang G, He G.

Life Sci. 2009 Aug 26;85(9-10):345-50. doi: 10.1016/j.lfs.2009.05.022. Epub 2009 Jun 13.

PMID:
19527735
8.

Inhibitory effects of 2,3,5,4'-tetrahydroxystilbene-2-O-beta-D-glucoside on experimental inflammation and cyclooxygenase 2 activity.

Zhang YZ, Shen JF, Xu JY, Xiao JH, Wang JL.

J Asian Nat Prod Res. 2007 Apr-Aug;9(3-5):355-63.

PMID:
17613621
9.

A noble function of BAY 11-7082: Inhibition of platelet aggregation mediated by an elevated cAMP-induced VASP, and decreased ERK2/JNK1 phosphorylations.

Lee HS, Kim SD, Lee WM, Endale M, Kamruzzaman SM, Oh WJ, Cho JY, Kim SK, Cho HJ, Park HJ, Rhee MH.

Eur J Pharmacol. 2010 Feb 10;627(1-3):85-91. doi: 10.1016/j.ejphar.2009.11.005. Epub 2009 Nov 10.

PMID:
19913011
10.

Rac1-mediated signaling plays a central role in secretion-dependent platelet aggregation in human blood stimulated by atherosclerotic plaque.

Dwivedi S, Pandey D, Khandoga AL, Brandl R, Siess W.

J Transl Med. 2010 Dec 6;8:128. doi: 10.1186/1479-5876-8-128.

11.

Levobupivacaine differentially suppresses platelet aggregation by modulating calcium release in a dose-dependent manner.

Liou JT, Mao CC, Liu FC, Lin HT, Hung LM, Liao CH, Day YJ.

Acta Anaesthesiol Taiwan. 2012 Sep;50(3):112-21. doi: 10.1016/j.aat.2012.07.001. Epub 2012 Sep 13.

12.

A new insight of anti-platelet effects of sirtinol in platelets aggregation via cyclic AMP phosphodiesterase.

Liu FC, Liao CH, Chang YW, Liou JT, Day YJ.

Biochem Pharmacol. 2009 Apr 15;77(8):1364-73. doi: 10.1016/j.bcp.2009.01.011. Epub 2009 Jan 29.

PMID:
19426675
13.

A potent antiplatelet peptide, triflavin, from Trimeresurus flavoviridis snake venom.

Huang TF, Sheu JR, Teng CM.

Biochem J. 1991 Jul 15;277 ( Pt 2):351-7.

14.

The effect of 2,3,4',5-tetrahydroxystilbene-2-O-β-D-glucoside on pressure overload-induced cardiac remodeling in rats and its possible mechanism.

Xu XL, Zhu QY, Zhao C, Wang F, Zhou ZY, Hu YE, Zhang W.

Planta Med. 2014 Feb;80(2-3):130-8. doi: 10.1055/s-0033-1360198. Epub 2014 Jan 15.

PMID:
24431015
15.

Biological properties of a specific Galpha q/11 inhibitor, YM-254890, on platelet functions and thrombus formation under high-shear stress.

Uemura T, Kawasaki T, Taniguchi M, Moritani Y, Hayashi K, Saito T, Takasaki J, Uchida W, Miyata K.

Br J Pharmacol. 2006 May;148(1):61-9.

16.

Impaired platelet responses to thrombin and collagen in AKT-1-deficient mice.

Chen J, De S, Damron DS, Chen WS, Hay N, Byzova TV.

Blood. 2004 Sep 15;104(6):1703-10. Epub 2004 Apr 22.

17.

Effect of aqueous extracts of several kinds of herbs on human platelet aggregation and expression of P-selectin in vitro.

Yan LG, Ruan JS, Zhang L, Fan FT, Zhang F, Wang AY, Zheng SZ, Zeng L, Li WL, Lu Y.

Chin J Integr Med. 2015 Apr;21(4):286-90. doi: 10.1007/s11655-013-1540-5. Epub 2014 Jan 28.

PMID:
24474672
18.

p-Terphenyl curtisian E inhibits in vitro platelet aggregation via cAMP elevation and VASP phosphorylation.

Kamruzzaman SM, Yayeh T, Ji HD, Park JY, Kwon YS, Lee IK, Kim S, Oh SH, Kim SD, Roh SS, Yun BS, Rhee MH.

Vascul Pharmacol. 2013 Sep-Oct;59(3-4):83-9. doi: 10.1016/j.vph.2013.07.002. Epub 2013 Jul 17.

PMID:
23872194
19.

Antiplatelet activity of Phellinus baummii methanol extract is mediated by cyclic AMP elevation and inhibition of collagen-activated integrin-α(IIb) β₃ and MAP kinase.

Kamruzzaman SM, Endale M, Oh WJ, Park SC, Kim TH, Lee IK, Cho JY, Park HJ, Kim SK, Yun BS, Rhee MH.

Phytother Res. 2011 Nov;25(11):1596-603. doi: 10.1002/ptr.3450. Epub 2011 Mar 11.

PMID:
21394810
20.

Inhibition of platelet-mediated arterial thrombosis and platelet granule exocytosis by 3',4'-dihydroxyflavonol and quercetin.

Mosawy S, Jackson DE, Woodman OL, Linden MD.

Platelets. 2013;24(8):594-604. doi: 10.3109/09537104.2012.749396. Epub 2012 Dec 18.

PMID:
23249183

Supplemental Content

Support Center